BR112017020203A2 - ?derivado de amina cíclica, medicamento, e, agente analgésico?. - Google Patents

?derivado de amina cíclica, medicamento, e, agente analgésico?.

Info

Publication number
BR112017020203A2
BR112017020203A2 BR112017020203-4A BR112017020203A BR112017020203A2 BR 112017020203 A2 BR112017020203 A2 BR 112017020203A2 BR 112017020203 A BR112017020203 A BR 112017020203A BR 112017020203 A2 BR112017020203 A2 BR 112017020203A2
Authority
BR
Brazil
Prior art keywords
amine derivative
cyclic amine
medicine use
present
pain
Prior art date
Application number
BR112017020203-4A
Other languages
English (en)
Japanese (ja)
Inventor
Osada Yuji
Izumimoto Naoki
Morita Yasuhiro
Udagawa Shuji
Iseki Katsuhiko
Miyoshi Tomoya
Iwano Shunsuke
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of BR112017020203A2 publication Critical patent/BR112017020203A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

o propósito da presente invenção é prover um composto com um efeito analgésico potente na dor, particularmente dor neuropática. a presente invenção provê um derivado de amina cíclica tipificado pela fórmula química (1) ou um sal farmacologicamente aceitável do mesmo.
BR112017020203-4A 2015-03-24 2016-03-24 ?derivado de amina cíclica, medicamento, e, agente analgésico?. BR112017020203A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015061249 2015-03-24
JP2015-061249 2015-03-24
PCT/JP2016/059293 WO2016152952A1 (ja) 2015-03-24 2016-03-24 環状アミン誘導体及びその医薬用途

Publications (1)

Publication Number Publication Date
BR112017020203A2 true BR112017020203A2 (pt) 2018-06-05

Family

ID=56977381

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017020203-4A BR112017020203A2 (pt) 2015-03-24 2016-03-24 ?derivado de amina cíclica, medicamento, e, agente analgésico?.

Country Status (9)

Country Link
US (1) US10253014B2 (pt)
EP (1) EP3275878B1 (pt)
JP (1) JP6645425B2 (pt)
CN (2) CN107250129A (pt)
BR (1) BR112017020203A2 (pt)
CA (1) CA2979326C (pt)
ES (1) ES2794560T3 (pt)
MX (1) MX2017011120A (pt)
WO (1) WO2016152952A1 (pt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031432A1 (en) 2001-10-12 2003-04-17 Novo Nordisk A/S Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
DE10211770A1 (de) * 2002-03-14 2003-10-02 Boehringer Ingelheim Pharma Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO2006137465A1 (ja) 2005-06-24 2006-12-28 Shionogi & Co., Ltd. 含窒素複素環誘導体
JPWO2013147160A1 (ja) 2012-03-29 2015-12-14 東レ株式会社 環状アミン誘導体及びその医薬用途
TWI652264B (zh) 2013-09-26 2019-03-01 東麗股份有限公司 Cyclic amine derivatives and their medical uses
MX2017010624A (es) * 2015-02-27 2017-12-07 Toray Industries Derivado de amina ciclica y su uso farmaceutico.
EP3275879B1 (en) * 2015-03-24 2020-01-15 Toray Industries, Inc. Cyclic amine derivative and pharmaceutical use thereof

Also Published As

Publication number Publication date
EP3275878B1 (en) 2020-05-20
US20180072701A1 (en) 2018-03-15
EP3275878A1 (en) 2018-01-31
WO2016152952A1 (ja) 2016-09-29
EP3275878A4 (en) 2018-09-19
CN107250129A (zh) 2017-10-13
JPWO2016152952A1 (ja) 2018-01-11
CN115124512A (zh) 2022-09-30
CA2979326A1 (en) 2016-09-29
CA2979326C (en) 2023-05-16
US10253014B2 (en) 2019-04-09
JP6645425B2 (ja) 2020-02-14
MX2017011120A (es) 2017-11-28
ES2794560T3 (es) 2020-11-18

Similar Documents

Publication Publication Date Title
PH12017501297A1 (en) Cyclic amine derivative and pharmaceutical use thereof
BR112015018738A8 (pt) compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica
BR112016011755A2 (pt) derivado de ureia ou sal farmacologicamente aceitável do mesmo
CY1120173T1 (el) Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης
BR112015021983A8 (pt) compostos heterocíclicos, composições e usos dos mesmos
BR112016018548A2 (pt) composto, ácido, medicamento, e, uso de um composto.
DOP2015000245A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
DOP2019000193A (es) Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende
BR112015016930A2 (pt) formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina
BR112020016020A8 (pt) Inibidor de atr e aplicação do mesmo
EA201591815A1 (ru) Бицикло [2.2.2] кислоты - модуляторы gpr120
BR112016006258A2 (pt) derivado de amina cíclica ou um sal farmacologicamente aceitável do mesmo, pró-droga, medicamento, e, agentes analgésico e terapêutico
BR112015029348A2 (pt) inibidores da bace
BR112015026967A8 (pt) fenoxietil di-hidro-1h-isoquinolina, seus usos, e composição farmacêutica
BR112018002127A2 (pt) derivado de ureia, e, inibidor de receptor de domínio de discoidina 1
BR112018072039A2 (pt) composto, medicamento, método, e, uso do composto ou sal do mesmo
PH12019500287A1 (en) Crystals of cyclic amine derivative and pharmaceutical use thereof
BR112017020180A2 (pt) derivados de aminohidrotiazina fundida em tetrahidrofurano que são úteis no tratamento da doença de alzheimer
BR112017020118A2 (pt) derivado aminado cíclico, medicamento, agente analgésico, e, agente terapêutico.
BR112017020203A2 (pt) ?derivado de amina cíclica, medicamento, e, agente analgésico?.
BR112019015428A2 (pt) Derivativos de pirrolotriazina como inibidor de quinase
BR112016008704A8 (pt) derivados de indol-urea glucopiranosil-substituídos, composições farmacêuticas, e seus usos
BR112016029571A2 (pt) compostos, composição farmacêutica e uso dos mesmos no tratamento de distúrbios neurodegenerativos
BR112019012020A8 (pt) Compostos de guanidina substituída
BR112018002118A2 (pt) ?derivado de ureia, e, inibidor de receptor de domínio de discoidina 1?

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]